Form 8-K - Current report:
SEC Accession No. 0001213900-22-071704
Filing Date
2022-11-14
Accepted
2022-11-14 09:20:27
Documents
14
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea168423-8k_longeveron.htm   iXBRL 8-K 29808
2 PRESS RELEASE OF THE COMPANY, DATED NOVEMBER 14, 2022 ea168423ex99-1_longeveron.htm EX-99.1 66063
3 GRAPHIC ex99-1_001.jpg GRAPHIC 23004
  Complete submission text file 0001213900-22-071704.txt   313487

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lgvn-20221114.xsd EX-101.SCH 3233
5 XBRL LABEL FILE lgvn-20221114_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE lgvn-20221114_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea168423-8k_longeveron_htm.xml XML 3708
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40060 | Film No.: 221381084
SIC: 2834 Pharmaceutical Preparations